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Diabetes mellitus is characterised by hyperglycaemia that is
associated with the occurrence of well described microvascular
complications that affect different organs, which development is
dependent on the duration of the disease and glycaemia control. For
many individuals with diabetes, episodes of severe hypoglycaemia
are a major complication of glycaemia control. Moreover, recurrent
hypoglycaemia impairs mechanisms of defence against hypoglyca-
emia. Thus, diabetes patients display a progressive decay in the
physiological counter-regulatory response, resulting in hypoglyca-
emia unawareness, and therefore prolonged exposure to hypoglyca-
emia insults may become lethal. One mechanism through which the
brain adapts to hypoglycaemiamay involve glycogenmetabolism and
its buffering effect on brain glucose concentrations. Conscious freely
moving rats were submitted to hypoglycaemia bellow 35 mg/dL for
90 minutes by insulin administration, followed by a recovery period
of 24 hours either under normoglycaemia or hyperglycaemia
achieved by glucose infusion. Rats were then sacriﬁced bymicrowave
ﬁxation and glycogen concentration was determined in different brain
regions. Control rats underwent the same treatment without the
preceding hypoglycaemia period. Hypoglycaemia depleted brain
glycogen content in the brain. In the cortex, glycogen concentration
was increased by 65 ± 27% or 114 ± 16% when recovery from
hypoglycaemia was performed under hyper- or normoglycaemia.
Similar glycogen supercompensation was observed in the hippocam-
pus but not in the hypothalamus and striatum. Brain glycogen
concentration did not increase after 24 hours under hyperglycaemia
without a preceding hypoglycaemia insult. In conclusion, supporting
brain metabolism during recurrent hypoglycaemia periods, glycogen
may have a role in hypoglycaemia unawareness.
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Feeding behavior and energy balance is maintenained through
integration of orexigenic and anorexigenic signals from the
periphery in the hypothalamus, in particular in the arcuate nucleus.
ARC neurons express anabolic Growth Hormone Secretagogue
Receptor (GHSR), catabolic leptin (Ob-R) and Melanocortin 4
(MC4R) receptors, to detect ghrelin, leptin and a-MSH, respec-
tively. Ghrelin is mainly produced in the stomach where, after
acylation by O-acyltransferase (GOAT), may bind to GHSR. Acyl-
ghrelin stimulates the gut-brain orexigenic axis to increase food
intake and reduce fat mobilization, in contrast to leptin, which,
circulating at levels proportional to body fat, promotes the synthesis
of the appetite suppressant a-MSH. To further understand how the
neuroendocrine ghrelin system regulates energy homeostasis
through the gut-brain-axis, we employed a novel approach to
reduce the endogenous ghrelin levels through the removal of the
stomach fundus by sleeve gastrectomy, the procedure of choice for
morbid obesity. We developed a rat obesity model, where animals
were fed a high fat diet for 12 weeks and then underwent sleeve
gastrectomy or sham operation. All animals were then fed normal
diet, and, when sacriﬁzed one or three months later, ghrelin and
GOAT in the stomach, GHSR, Ob-R and MC4R expression levels in
the hypothalamus were assessed by semi-quantitative RT-PCR and
immunodetection. We found that sleeve gastrectomy signiﬁcantly
decreased ghrelin message in the stomach when compared to sham-
and non-operated animals. GOAT patterns followed that of ghrelin
suggesting co-regulation of their expression as well as acylation of
ghrelin. In the hypothalamus we observed decreased GHSR and Ob-
R expression both at the message and protein levels, possibly due to
lower acyl-ghrelin levels. As expected, lower fat and thus lower
leptin levels, led to signiﬁcantly lower expression of MC4R, upon
withdrawal from the fat diet for at least 3-months. Our results
indicate that ghrelin participates in the control of energy balance
through the regulation of its own receptor GHSR, Ob-R and MC4R
expression in the hypothalamus of obese animals.
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Alzheimer’s disease (AD) has been linked to defective brain
insulin signaling, a proposed third type of diabetes (1, 2, 3).
Although this intriguing connection between AD and diabetes has
been suggested, a major unknown is the mechanism by which
insulin resistance develops in AD brains. In type 2 diabetes, tumor
necrosis factor-a (TNF- a) signaling stimulates c-Jun N-Terminal
Kinase (JNK). This results in serine phosphosphorylation of the
insulin receptor substrate (IRS-1), blocking downstream signaling
and triggering insulin resistance (4). The link between diabetes and
Alzheimer¢s disease was found in the ability of Ab oligomers, toxins
that accumulate in Alzheimer brain and instigate synaptic damage,
to activate the JNK/TNF-a pathway leading to phosphorylation of
IRS-1pSer636. The aim of this study was to investigate whether Ab
oligomers injected into the cerebral ventricles of adult cynomolgus
monkeys are capable of triggering mechanisms similar to those
described for type 2 diabetes. Our ﬁndings indicate JNK activation
and increased levels of IRS-1pSer636 in primate hippocampus.
They reinforce the link between diabetes and AD. Furthermore,
considering the dearth of animal model systems that truly recapit-
ulates the main features of Alzheimer’s disease, this new non-human
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